Dipyridamole (D) reduces the effectiveness of prostaglandin (PG) I2, PGD2 and PGE1 as inhibitors of platelet aggregation in human platelet-rich plasma (PRP)

G. Di Minno, G. De Gaetano, M. J. Silver

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalThrombosis and Haemostasis
Issue number1
Publication statusPublished - 1979

ASJC Scopus subject areas

  • Hematology

Cite this